Cargando…
(18)F-fluorodeoxyglucose positron emission tomography/ computed tomography in the diagnosis of suspected paraneoplastic syndromes: A retrospective analysis
Paraneoplastic syndromes are a rare clinical presentation of tumor thought to affect 0.01% of patients with cancer. Paraneoplastic syndromes present a diagnostic challenge as a wide variety of signs and symptoms may appear. This study examines the use of (18)F-fluorodeoxyglucose positron emission to...
Autores principales: | Bresler, Richard, Schroeder, Harry William, Chow, David Z., Lim, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478297/ https://www.ncbi.nlm.nih.gov/pubmed/32939199 http://dx.doi.org/10.4103/wjnm.WJNM_48_19 |
Ejemplares similares
-
Paraneoplastic Hyperfibrinolysis: Detection of Occult Prostate Cancer with 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
por: Sharma, Punit
Publicado: (2021) -
Paraneoplastic syndrome turned out to be non-Hodgkin's lymphoma on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography
por: Sahoo, Manas Kumar, et al.
Publicado: (2016) -
Paraneoplastic Syndrome Presenting with Polymyalgia Rheumatica-like Accumulations on (18)F-fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Umetsu, Ayaka, et al.
Publicado: (2018) -
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart
por: Kong, Eunjung
Publicado: (2020) -
Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)